Clinical Observation of Atomization and Inhalation Therapy of Yiqi Qufeng Decoction for Symptoms and Quality of Life of Patients with Biqiu and Deficiency-cold of Lung Qi
HU An-mei, LEI Xia, ZHAO Yan-li, et al. Clinical Observation of Atomization and Inhalation Therapy of Yiqi Qufeng Decoction for Symptoms and Quality of Life of Patients with Biqiu and Deficiency-cold of Lung Qi[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(4): 197-202.
HU An-mei, LEI Xia, ZHAO Yan-li, et al. Clinical Observation of Atomization and Inhalation Therapy of Yiqi Qufeng Decoction for Symptoms and Quality of Life of Patients with Biqiu and Deficiency-cold of Lung Qi[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(4): 197-202. DOI: 10.13422/j.cnki.syfjx.2018040197.
Objective: To discuss the clinical effect of atomization and inhalation therapy of Yiqi Qufeng decoction on symptoms and quality of life in patients with Biqiu (allergic rhinitis
AR) and deficiency-cold of lung Qi
as well as its effects on levels of interleukin-4 (IL-4)
IL-5
IL-13 and cysteinyl leukotrienes (CYs-LTs). Method: One hundred and fifty patients were randomly divided into control group (75 cases) and observation group (75 cases) by random number table. Patients in control group got mometasone furoate aqueous nasal spray
1 spray/nostril
once for every night. Patients in observation group got atomization and inhalation therapy of Yiqi Qufeng decoction
1 time/day
20 min/time. The treatment course was 14 days for both groups. Before and after treatment
main symptom scores and rhinoconjunctivitis quality of life questionnaire (RQLQ) were graded. Nose resistance and levels of total IgE (TIgE)
specificity (sIgE)
IL-4
IL-5
IL-13 and CYs-LTs were detected. The level of eosinophils was tested after treatment. Result: The total effective rate was 91.55% in observation group. Higher than 78.57% in control group (χ2=4.683
P<0.05). After treatment
the item scores and the total sores of main symptoms such as nasal congestion
nasal itching
sneeze
runny nose
itchy eyes
foreign body sensation
red eyes and tears in observation group were lower than those in control group (P<0.01). Dimensional scores and the total score of RQLQ in observation group were all lower than those in control group after treatment(P<0.01). Nose resistance in observation group was lower than that in control group (P<0.01)
and levels of TIgE
sIgE
CYs-LTs
IL-4
IL-5 and IL-13 were lower than those in control group (P<0.01). Conclusion: Atomization and inhalation therapy of Yiqi Qufeng decoction in patients with Biqiu can relieve clinical symptoms and degree of sensitization
decrease nose resistance
improve quality of life
and inhibit inflammation symptoms
and its clinical efficacy was better than that of mometasone furoate.